Saturday, March 13, 2010 |
|
|
|
 |
Q&A with Wesley M. Granger, Respiratory Care Program Director at the University of Alabama at BirminghamWesley M. Granger, PhD, RRT, is a Registered Respiratory Therapist with a BA in Microbiology and a PhD in Physiology. Wesley started out as an emergency room orderly, and then moved on to the field of... Would you like to be featured in a NEWS-Line editorial? Click Here |
Feature Story
|
NewsFDA Advisory Committee Recommends Approval of InterMune's Esbriet for Idiopathic Pulmonary Fibrosis
InterMune, Inc. announced that the US Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbriet (pirfenidone) for the treatment... Full Article (0 Comments)
ATS Issues Statement on Disorder of Respiratory & Autonomic Nervous System Regulation
The American Thoracic Society has released a new official clinical policy statement on congenital central hypoventilation syndrome (CCHS), a disorder of respiratory and autonomic nervous system (ANS) ... Full Article (0 Comments)
Daylight-Saving Time Switch May Leave You Sleepy
[Don't forget to set your clocks ahead this Sunday, March 14! ~JC] Many Americans will lose an hour of sleep on March 14, the first day of daylight-saving time, when clocks are set ahead one hour at ... Full Article (0 Comments)
Wonder How Bad Your Allergies Will Be This Spring?
[It's that time again...here comes allergy season. ~JC] With record-setting snowfall and wet weather in the region this winter, one question comes to mind for many as spring approaches: how bad will ... Full Article (0 Comments)
Symbicort Demonstrated Reversibility in Airflow Obstruction in Patients across Multiple Levels of COPD Severity
An additional post-hoc data analysis of patients with COPD showed that SYMBICORT Inhalation Aerosol demonstrated reversibility of airflow obstruction in a large percentage of patients (52%) across mul... Full Article (0 Comments)
